University of Missouri School of Medicine MU Health School of Medicine
News Divider

World Ophthalmology Congress Brings MU Discoveries Into Focus

Nanomedicine research could help millions suffering from corneal conditions

Rajiv Mohan, PhD
A University of Missouri research program that examines how nanotechnology could treat corneal diseases will be featured at the 2010 World Ophthalmology Congress from June 5 to June 9, 2010. Rajiv Mohan, PhD, associate professor of ophthalmology at the MU School of Medicine, will present how nanoparticles could be paired with therapeutic genes to deliver new treatments to corneal tissue. The promising new therapy could help millions who suffer from corneal scarring, wounds and other conditions.

Mohan was one of only five basic scientists invited to make a presentation at the nanotechnology session of the meeting, which will draw more than 6,000 attendees to Berlin.

"Because the meeting is primarily for physicians to discuss clinical care, basic science research that is presented must be able to translate from the bench to the bedside," Mohan said. "This selection is a direct reflection of MU's commitment to translational research in ophthalmology and to discoveries campuswide."

The cornea is the dome-shaped surface that functions as the eye's outermost layer. It is the first line of defense in shielding the eye from injury as well as infections. Corneal haze, scarring and abnormal blood vessel development are among the leading causes of vision impairment in the world and affect approximately 1.5 million Americans every year. Abnormal wound healing due to corneal injury or infection has been shown to play a critical role in causing these and other corneal disorders and diseases.

Mohan's laboratory is researching how hybrid gold nanoparticles and biodegradable polymeric nanoparticles can be used as a nonviral carrier to deliver gene therapy to the cornea. The nanoparticle-based gene therapy has shown minimal side effects in preclinical studies.

"The current nonviral vectors, or gene delivery vehicles, are incapable of delivering therapeutic levels of genes into the cells of the cornea," Mohan said. "Nanoparticles, because they are smaller, could provide a less invasive option for delivering the gene therapy effectively while reducing the risk of infection and side effects from treatment."

Mohan's corneal gene therapy research is funded by more than $2.8 million in grants from the National Eye Institute and Department of Veterans Affairs. The Association for Research in Vision and Ophthalmology recently identified findings from his laboratory as among the "the newest and most innovative" in the field of nanotechnology for drug and gene delivery.

The World Ophthalmology Congress brings together ophthalmologists to enhance education and improve access to the highest quality eye care. More information about its efforts to preserve and restore vision is available at

MU Health Magazine


News and Events

Kimchi Kimchi Named Medical Director of Cancer Center
Accomplished academic physician also leads Division of Surgical Oncology

Sherman New Predictor of Health Complications Can Identify High-Risk Preemies
Blood eosinophilia predicts deadly complications for preemies with necrotizing enterocolitis

Padilla A Short Walk Around the Office Can Reverse Vascular Dysfunction Caused by Hours at a Computer
Short walks after sitting can offset the harm caused to vascular blood vessels

Coulter MU Awards Five Grants to Accelerate Biomedical Discoveries from Lab to Market
Coulter program pairs physicians, engineers to develop new health technologies

Bill Folk (Un)common Folk
Biochemistry stalwart prepares to share his story for Corps of Discovery Lecture

Boerman Researchers Identify Mechanism that Impairs Blood Flow with Aging
New findings could lead to treatments for age-related vascular disease

Koopman Clinic Notes Should Be Re-Engineered to Meet Needs of Physicians
Better documentation tools can lead to more efficient, safer patient care

Altes named Radiology Chair Altes Named MU Radiology Chair
Altes excels in bench to bedside research, teaching and mentoring students, and clinical care

Protein Packed Breakfast Protein-Packed Breakfast Prevents Body Fat Gain in Overweight Teens
High-protein breakfast also improves teens’ glycemic control

White Coat Ceremony 2015 White Coat Ceremony Marks Start of Professional Journey for 104 Students
Students receive 'cloak of compassion' and pledge to uphold medicine's highest values

Eduardo Simoes, MD Tool Helps Public Health Agencies Prioritize Health Risks
Researcher works with Brazil to identify top risks for chronic diseases

Washington and Khosla U.S. South Asians More Reluctant to Seek Medication for Pain
Health care workers should be culturally aware when caring for patients, families

Segal Blood Vessels Can Actually Get Better With Age
Study finds that arteries adapt to oxidative stress caused by aging

Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
(573) 882-7299

Jeff Hoelscher
(573) 884-1608

Derek Thompson
(573) 882-3323

Diamond Dixon
(573) 884-7541

Justin Kelley (Photographer)
(573) 882-5786
Pager (573) 397-9289

Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Laura Gerding, APR
(573) 882-9193

Velvet Hasner
(573) 884-1115

Justin Willett
(573) 884-7740

Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: April 27, 2013 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.